How It Works
Clinical trial candidates are not medical mysteries. They typically have an existing diagnosis, are on an existing medication, and in a relationship with an existing physician. MedVector unlocks access to millions of these patients by allowing specialists, and other point-of-care trusted physicians, to offer advanced medicine as a care option without triggering new clinical trial sites. We partner with sponsors, CROs, and existing patient recruitment companies to connect participants beyond geographic and socioeconomic barriers, improving diversity and eliminating participant enrollment delays triggering new clinical trial sites.
It’s All About Access

Watch Our Explainer Video


The MedVector Window

The MedVector Window uses proprietary technology to put the Participant and the Investigator face-to-face, as if they are in the same room.  It enables the investigator site to literally “supervise” the delegated tasks performed by a local nurse.

Challenges of BYOD

Too many variables.

Variations add to risk and cost…

    • Different Hardware / Cameras
    • Broken Components
    • Small Screen Size
    • Multiple OS
    • Poor Bandwidth
    • User Ability / User Care
    • Passwords and Settings

Why Hardware?

Doctor-Centric – Enables study specific software and hardware to be pre-installed without data integration at the local facility or disrupting the local practice.

Prime-Control – The MedVector Window acts as a physical extension of the clinical trial site enabling the investigator team to control connected devices like they are in the same room.

Scalable & Portable – The MedVector Window is managed, maintained, and repositioned by MedVector, reducing training costs, installation fees, and connected device fees.

Plug & Play – It knows where it is and why it’s there, which minimizes privacy and security risks, while maximizing ease of use.

What Industry Leaders Are Saying
Kathy Freeman
Executive Director, Inspire

“It’s hard to find participants for oncology and rare diseases. They have strong relationships with their specialists, and specialists are more likely to provide access to their patients if they can stay within their practice to participate in a clinical study. MedVector’s innovative platform provides the key to unlock access to millions of patients.”

John Neal
Founder and Chairman of PCRS Network

“Data is useless if you can’t access the patient. Now that we’ve seen what telemedicine can do, the clinical trials industry is ready for MedVector’s innovative technology, which connects patients at local providers with investigators at existing clinical trial sites. This means participants are no longer geographically limited.”

Craig Lipset
Co-Chair, Decentralized Trials & Research Alliance

MedVector’s solution couples widely accepted telemedicine with an innovative business partnering model to open research access at the location patient’s trust most – their local doctor’s office. That is a market innovation we can all get behind.”